PMC:7172841 / 1131-1286 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T12","span":{"begin":44,"end":47},"obj":"Body_part"},{"id":"T13","span":{"begin":105,"end":113},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":66,"end":77},"obj":"Disease"},{"id":"T17","span":{"begin":135,"end":147},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0003783"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":26,"end":28},"obj":"Chemical"},{"id":"T11","span":{"begin":48,"end":50},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A10","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T9","span":{"begin":105,"end":124},"obj":"http://purl.obolibrary.org/obo/GO_0001816"},{"id":"T10","span":{"begin":135,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T7","span":{"begin":66,"end":77},"obj":"Phenotype"}],"attributes":[{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0001888"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T41","span":{"begin":26,"end":30},"obj":"PR:000001393"},{"id":"T42","span":{"begin":44,"end":47},"obj":"PR:000029150"},{"id":"T43","span":{"begin":51,"end":61},"obj":"GO:0010467"},{"id":"T88472","span":{"begin":26,"end":30},"obj":"PR:000001393"},{"id":"T6458","span":{"begin":44,"end":47},"obj":"PR:000029150"},{"id":"T72315","span":{"begin":51,"end":61},"obj":"GO:0010467"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}

{"project":"LitCovid-PubTator","denotations":[{"id":"43","span":{"begin":26,"end":30},"obj":"Gene"},{"id":"64","span":{"begin":66,"end":77},"obj":"Disease"},{"id":"65","span":{"begin":129,"end":147},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Gene:3569"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D008231"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ID-19 is characterized by IL-6-mediated low HLA-DR expression and lymphopenia, associated with sustained cytokine production and hyper-inflammation.\n\nGraph"}